BACKGROUND: The long-term health outcomes and costs of helicopter emergency medical services (HEMS) assistance remain uncertain. The aim of this study was to investigate the cost-effectiveness of HEMS assistance compared with emergency medical services (EMS). METHODS: A prospective cohort study was performed at a level I trauma centre. Quality-of-life measurements were obtained at 2 years after trauma, using the EuroQol-Five Dimensions (EQ-5D) as generic measure to determine health status. Health outcomes and costs were combined into costs per quality-adjusted life year (QALY). RESULTS: The study population receiving HEMS assistance was more severely injured than that receiving EMS assistance only. Over the 4-year study interval, HEMS assistance saved a total of 29 additional lives. No statistically significant differences in quality of life were found between assistance with HEMS or with EMS. Two years after trauma the mean EQ-5D utility score was 0.70 versus 0.71 respectively. The incremental cost-effectiveness ratio for HEMS versus EMS was 28,327 Euro per QALY. The sensitivity analysis showed a cost-effectiveness ratio between 16,000 and 62,000 Euro. CONCLUSION: In the Netherlands, the costs of HEMS assistance per QALY remain below the acceptance threshold. HEMS should therefore be considered as cost effective.
BACKGROUND: The long-term health outcomes and costs of helicopter emergency medical services (HEMS) assistance remain uncertain. The aim of this study was to investigate the cost-effectiveness of HEMS assistance compared with emergency medical services (EMS). METHODS: A prospective cohort study was performed at a level I trauma centre. Quality-of-life measurements were obtained at 2 years after trauma, using the EuroQol-Five Dimensions (EQ-5D) as generic measure to determine health status. Health outcomes and costs were combined into costs per quality-adjusted life year (QALY). RESULTS: The study population receiving HEMS assistance was more severely injured than that receiving EMS assistance only. Over the 4-year study interval, HEMS assistance saved a total of 29 additional lives. No statistically significant differences in quality of life were found between assistance with HEMS or with EMS. Two years after trauma the mean EQ-5D utility score was 0.70 versus 0.71 respectively. The incremental cost-effectiveness ratio for HEMS versus EMS was 28,327 Euro per QALY. The sensitivity analysis showed a cost-effectiveness ratio between 16,000 and 62,000 Euro. CONCLUSION: In the Netherlands, the costs of HEMS assistance per QALY remain below the acceptance threshold. HEMS should therefore be considered as cost effective.
Authors: M Kit Delgado; Kristan L Staudenmayer; N Ewen Wang; David A Spain; Sharada Weir; Douglas K Owens; Jeremy D Goldhaber-Fiebert Journal: Ann Emerg Med Date: 2013-04-09 Impact factor: 5.721
Authors: Juanita A Haagsma; Akkie N Ringburg; Esther Mm van Lieshout; Ed F van Beeck; Peter Patka; Inger B Schipper; Suzanne Polinder Journal: BMC Psychiatry Date: 2012-12-27 Impact factor: 3.630
Authors: D Bäckström; R Larsen; I Steinvall; M Fredrikson; R Gedeborg; F Sjöberg Journal: Eur J Trauma Emerg Surg Date: 2017-08-20 Impact factor: 3.693
Authors: K S Funder; L S Rasmussen; R Hesselfeldt; V Siersma; N Lohse; A Sonne; S Wulffeld; J Steinmetz Journal: Acta Anaesthesiol Scand Date: 2017-01 Impact factor: 2.105
Authors: Georgios F Giannakopoulos; Wouter D Lubbers; Herman M T Christiaans; Pieternel van Exter; Piet Bet; Paul J C Hugen; Gerard Innemee; Edo Schubert; Elly S M de Lange-Klerk; J Carel Goslings; Gerrolt N Jukema Journal: Langenbecks Arch Surg Date: 2010-01-19 Impact factor: 3.445
Authors: Robert Gałązkowski; Michał M Farkowski; Daniel Rabczenko; Marta Marciniak-Emmons; Tomasz Darocha; Dariusz Timler; Maciej Sterliński Journal: Arch Med Sci Date: 2016-08-18 Impact factor: 3.318